Kane Biotech (KNBIF) 0.0295 $KNBIF Kane Biotech

New Post Public Reply Private Reply Replies (0) Message Board

Jul 26, 2016 at 11:10 PM

Kane Biotech (KNBIF) 0.0295 $KNBIF

Kane Biotech Announces Board Members
Marketwired - Mon Jun 06, 7:02AM CDT
WINNIPEG, MANITOBA--(Marketwired - Jun 6, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that at the Company's Annual and Special Meeting of shareholders held on June 2, 2016 (the "Meeting"

, the following individuals were elected to the board of directors: Philip Renaud (Chairman), Dr. Arvind Joshi, Mark Nawacki, Dr. Sarah Prichard, Mark Ahrens-Townsend and Marc Edwards. Each Director is to serve for a term of one year or until their successors are elected or appointed.
KNE.VN: 0.025 (-0.005)

Kane Biotech Announces Private Placement Offering and Proposed Consolidation of Shares
Marketwire Canada - Thu Jun 02, 4:33PM CDT
WINNIPEG, MANITOBA--(Marketwired - Jun 2, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"

today announced the intention of the Company to undertake a non-brokered private placement offering (the "Offering"

of up to 50,000,000 common shares ("Common Shares"

at a price of $0.03 per Common Share for gross proceeds of up to $1,500,000. The net proceeds of the Offering will be used for development and marketing of the Company's products and for general working capital.
KNE.VN: 0.025 (-0.005)

Philip Renaud Files Early Warning Report in Respect of Kane Biotech Inc.
Marketwired - Thu May 05, 5:23PM CDT
LONDON, UNITED KINGDOM--(Marketwired - May 5, 2016) - Philip Renaud (11 The Little Boltons, London, England, SW10 9LT), the Chairman and a director of Kane Biotech Inc. (the "Corporation"

, today announces that he and an entity over which he exercises control have acquired 28,408,146 common shares ("Common Shares"

of the Corporation in connection with the Corporation's previously announced rights offering (the "Rights Offering"

, as described in the Corporation's Rights Offering circular dated March 30, 2016.

Kane Biotech Announces Insider Participation in Rights Offering
Marketwire Canada - Wed May 04, 5:07PM CDT
WINNIPEG, MANITOBA--(Marketwired - May 4, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"

is pleased to announce additional information regarding the participation of the insiders of the Company in the rights offering (the "Rights Offering"

of the Company that closed on May 3, 2016.
KNE.VN: 0.025 (-0.005)

Kane Biotech Announces Rights Offering Closing
Marketwired - Wed May 04, 7:02AM CDT
WINNIPEG, MANITOBA--(Marketwired - May 4, 2016) - Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"

is pleased to announce the closing of its rights offering (the "Rights Offering"

originally announced on March 29, 2016.
KNE.VN: 0.025 (-0.005)

Kane Biotech Announces bluestem(TM) Breakthrough Order with Major Retail Chain
Marketwired - Tue Apr 26, 4:50PM CDT
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Company" or "Kane Biotech" or "Kane"

is pleased to announce that it has received a breakthrough order of its bluestem(TM) brand of oral care products from a major North American pet specialty store chain. The chain is one of the largest and fastest growing pet retailers in North America dedicated to providing families with food and supplies for their pets.
KNE.VN: 0.025 (-0.005)

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Marketwired - Thu Apr 07, 11:30AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation"

announced that on April 7, 2016, it issued 254,369 common shares of the Corporation ("Common Shares"

in payment of $12,718.45 in interest owing on the Corporation's $500,000 2 year 10% convertible redeemable unsecured note (the "Note"

as at March 18, 2016. Pursuant to the terms of the Note, the Corporation has the option to issue Common Shares in lieu of cash in payment of interest on the Note at a deemed price per share equal to the market price of the Common Shares on the applicable interest payment date, subject to a minimum price of $.05 per share and the approval of the TSX Venture Exchange (the "Exchange"

. The approval of the Exchange for the issuance of the Common Shares was obtained by the Corporation on March 23, 2016. The Common Shares issued by the Corporation are restricted from transfer for a period of four months from the date of issuance in accordance with applicable securities laws and TSX Venture Exchange policies.
KNE.VN: 0.025 (-0.005)

Kane Biotech Announces Rights Offering
Marketwire Canada - Tue Mar 29, 3:52PM CDT
Kane Biotech Inc. (TSX VENTURE:KNE) (the "Company" or "Kane Biotech"

today announced that it will be offering rights ("Rights"

to holders ("Shareholders"

of its common shares ("Common Shares"

of record as at 5:00 p.m. (Toronto time) on April 5, 2016 (the "Record Date"

, on the basis of one Right for each Common Share held (the "Rights Offering"

. Each Right will entitle the holder thereof to subscribe for one Common Share upon payment of the subscription price of $0.03 per Common Share. The Rights Offering will be conducted only in the provinces and territories of Canada (the "Eligible Jurisdictions"

. Accordingly, and subject to the detailed provisions of Kane Biotech's rights offering circular in respect of the Rights Offering (the "Circular"

, Rights will not be delivered to, nor will they be exercisable by, persons resident outside the Eligible Jurisdictions. Rather, such Rights may be sold on their behalf.
KNE.VN: 0.025 (-0.005)

Kane Biotech Announces Private Placement Offering
Marketwired - Wed Jan 27, 7:02AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Company" or "Kane Biotech"

today announced the intention of the Company to undertake a non-brokered private placement offering (the "Offering"

of up to 66,666,667 units ("Units"

at a price of $0.06 per Unit for gross proceeds of up to $4,000,000. Each Unit shall be comprised of one common share of the Company (a "Share"

and one half of one Share purchase warrant (a "Warrant"

. Each whole Warrant shall entitle the holder thereof to purchase one Share at a price of $0.10 per Share for a period of 18 months from the date of issuance of the Warrant. Insiders of Kane Biotech have informed the Company they will be participating in the Offering.
KNE.VN: 0.025 (-0.005)

Kane Biotech Receives $240,000 From Warrant Exercise
Marketwired - Fri Jan 08, 7:01AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation"

announced that between December 30, 2015 and January 4, 2016 it received $240,000 from the exercising of 4,000,000 warrants at $.06 per share. The warrants were issued on December 9, 2014 as part of a previous financing. The warrants were exercised by family members of an insider of the Corporation.
KNE.VN: 0.025 (-0.005)

Kane Biotech Appoints New CFO and Announces Addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options
Marketwired - Tue Jan 05, 7:02AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation"

, a biotechnology company developing and commercializing products that prevent and remove microbial biofilms, is pleased to appoint Audrey Goertzen CPA, CGA as Kane Biotech's new Chief Financial Officer (CFO) replacing Mark Matthewson CPA, CA, effective January 4, 2016. Ms. Goertzen has broad experience in financial management and accounting over the past 22 years in public accounting, public and government crown corporations, as well as rapidly growing entrepreneurial companies. Mr. Matthewson's services had been provided to Kane Biotech through a Management Services Agreement with MKM Management Services Ltd.
KNE.VN: 0.025 (-0.005)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Feeding Families Foundation Gains $121,500 for NYC Push

Holy smokes, here comes some good news in the nonprofit corners! Feeding Families Foundation just got a hefty $121,500 boost from the Association of Contracting Plumbers of the City of New York Inc. This ain't just some pocket change; it's a full-fledged lifeline that helps them keep on delivering meals to parents who are practically living at their kid’s hospital...

Perk's U.S. Expansion: A Bold Move in Spend Control

Perk Aims for U.S. Growth: Will It Pay Off? Amidst the cacophony of market chatter, Perk's announcement to bring its spend platform stateside is echoing louder than usual. This move is not just another step in its expansion but rather a leap considering the competition and market needs. In Europe, where they've already captured a chunk of the market with their Travel and...

Rosewood HK Tops Best Hotel List Again; Asia Shines

Holding the Crown: Rosewood Hong Kong's Triumph When a single hotel keeps nabbing the top spot in the world's most prestigious rankings, it's worth taking a closer look. That's exactly what's happening with Rosewood Hong Kong, crowned the world's best once more in 2026—its second consecutive year at the pinnacle according to The 50 Best Hotels. Defining Luxury on a...

Alcott HR's Sales Strategy Gets a Boost with New Hire

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

MasterBrand's 2027 Kitchen Trends: Embrace Warmth

Wood Finishes and the Warm Embrace Alright folks, let's cut through the fluff and get to the heart of the matter: wood finishes are making a roaring comeback in 2027 kitchens. And it's not just some passing phase, we're talking a comprehensive shift toward warmer and more natural kitchen designs. MasterBrand, Inc. isn't just throwing darts at a board here. They surveyed a...

G-STAR & Wu-Tang Clan Unleash Denim Fusion

Denim and Old-School Beats: A Fresh Partnership Just when you think fashion collaborations have run their course, along comes something worth the buzz. This fall, G-STAR, the edgy Dutch denim frontrunner, and the legendary hip-hop collective of Wu-Tang Clan are shaking up the apparel scene, blending raw denim with raw rap. It's a multi-year collaboration that doesn't slap...

Avive Partners with Cambridge Fire for Lifesaving Training

Tapping into the Pulse: Avive & Cambridge Fire in Action No fooling around here—Avive Solutions is linking arms with the Cambridge Fire Department to put the city on a faster track to becoming a lifesaver haven. They're rolling out a free CPR and AED training right in the Smith Campus Center, Harvard Square. It's the kind of thing you love to see—getting the community...

Inovonics Duress Card Enhances Safety for K-12 and Beyond

A New Dawn for Safety in Schools and More It's about time we talk about something more substantial than just beefing up security cameras or tightening door locks. Real-world problems require nimble solutions, and that's where Status Solutions steps in with the Inovonics Duress Card. It's not just another gadget; it's a lightweight, wrist-mounted lifeline designed to say,...

CSS Revamps Identity, Emphasizing Senior Living Tech

CSS Takes a Bold Step with a Fresh Brand Identity Every now and then, you see a company shake off the old coat and put on a polished new one. That's what CSS is doing with its updated brand, staking its claim as a heavyweight tech player in the senior living sector. No small feat, given the challenges stacked against these aging communities—tasked with keeping...

Citrine Finalizes Sale of Illinois Senior Living Asset

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...